Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1
The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc
Veteran equity markets leader joins to oversee trading operations and advance cross-platform growth initiatives NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities. In this role, Peterson will oversee all supervisory and operational activities for Oppenheimer's equity sales and trading team, working closely with other leaders in the Equities division and across the firm to ensure continued
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc
Veteran equity markets leader joins to oversee trading operations and advance cross-platform growth initiatives NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities. In this role, Peterson will oversee all supervisory and operational activities for Oppenheimer's equity sales and trading team, working closely with other leaders in the Equities division and across the firm to ensure continued
Addition of respected industry veteran highlights the rapid expansion of the firm's Public Finance team NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced it has hired Guy T. Logan to serve as Managing Director, Head of Infrastructure & Mid-Atlantic Region within the firm's Public Finance Investment Banking Division. He will report to Beth Coolidge, Managing Director and Head of Public Finance. Logan joins Oppenheimer with more than 30 years of municipal finance experience. Over the course of his career, he has served as senior or lead banker on more th
NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1
NEW YORK, Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quarter of 2025, compared with net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024. Third quarter 2025 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $13.5 million or $0.95 basic earnings per share (after tax), attributable to an increase in the OPY Class A share price (increased $8.30 per share during the quarter). Revenue for the third quarter of 2025 was $424.4 million, an increase of 13.7%, comp
NEW YORK, Aug. 1, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. Robert S. Lowenthal, President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several yea
SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)
SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)